Repare Therapeutics Inc (RPTX) — Capital Reinvestment Ratio
Repare Therapeutics Inc (RPTX) has a Capital Reinvestment Ratio of 0.00x as of September 2022, meaning it reinvests 0% of its operating cash flow ($88.16 Million) in capital expenditures ($266.00K). See RPTX net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Repare Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Repare Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Repare Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Repare Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Repare Therapeutics Inc from 2022 to 2022. For live market cap and broader valuation context, see RPTX company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.87x | $322.00K | $602.00K | — |